US Bancorp
ELGX

US Bancorp’s Endologix Inc ELGX Stock Holding History

US Bancorp’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-946
Closed -$46K – 3699
2017
Q2 		$46K Sell
946
-33
-3% -$1.94K ﹤0.01% 2584
2017
Q1 		$71K Sell
979
-240
-20% -$15.9K ﹤0.01% 2310
2016
Q4 		$70K Buy
1,219
+218
+22% +$20K ﹤0.01% 2288
2016
Q3 		$128K Sell
1,001
-337
-25% -$43.1K ﹤0.01% 1973
2016
Q2 		$167K Buy
1,338
+546
+69% +$62.8K ﹤0.01% 1775
2016
Q1 		$66K Buy
792
+75
+10% +$6.18K ﹤0.01% 2246
2015
Q4 		$71K Buy
717
+370
+107% +$39.7K ﹤0.01% 2265
2015
Q3 		$43K Sell
347
-484
-58% -$65.7K ﹤0.01% 2536
2015
Q2 		$127K Sell
831
-233
-22% -$38.4K ﹤0.01% 2008
2015
Q1 		$181K Sell
1,064
-553
-34% -$83.8K ﹤0.01% 1836
2014
Q4 		$247K Buy
1,617
+456
+39% +$56.9K ﹤0.01% 1670
2014
Q3 		$123K Sell
1,161
-240
-17% -$33.4K ﹤0.01% 2001
2014
Q2 		$213K Sell
1,401
-354
-20% -$47.1K ﹤0.01% 1774
2014
Q1 		$226K Buy
1,755
+883
+101% +$137K ﹤0.01% 1712
2013
Q4 		$152K Buy
872
+672
+336% +$115K ﹤0.01% 1874
2013
Q3 		$32K Sell
200
-900
-82% -$142K ﹤0.01% 2512
2013
Q2 		$147K Buy
+1,100
New +$155K ﹤0.01% 1803

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

US Bancorp's ELGX Position: Q3 2017 in Review

US Bancorp sold out of Endologix Inc (ELGX) in Q3 2017, closing a stake of 946 shares — an estimated $46K sold.

US Bancorp first reported a position in ELGX in Q2 2013 and held it in 17 quarters. The position peaked at $247K in Q4 2014. 106 funds tracked by Wall St. Rank hold ELGX as of Q3 2017.

  • US Bancorp reported no remaining Endologix Inc position as of Q3 2017 after selling out during the quarter.
  • US Bancorp sold 946 Endologix Inc shares in Q3 2017, an estimated $46K.
  • US Bancorp first reported a position in Endologix Inc in Q2 2013 and held it in 17 quarters.
  • US Bancorp's Endologix Inc position peaked at $247K in Q4 2014.
  • 106 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2017.

Based on US Bancorp's 13F filing for Q3 2017, filed 13 Nov 2017.